Mali

Reimbursed Care Access

Mali regulates narcotics and psychotropic substances under national drug-control legislation that limits use to medical and scientific purposes; many classic psychedelics (psilocybin, MDMA, DMT, mescaline, etc.) are listed among controlled substances and have no authorized medical use outside research. Ketamine is present in the national pharmaceutical system for anesthetic/clinical use but advanced licensed psychedelic medicines such as esketamine are not authorized and public reimbursement for novel psychedelic treatments is effectively nonexistent. Enforcement and import/export are also controlled by customs and national decrees that implement international drug conventions.